Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma

Serena De Matteis, Anna Maria Granato, Roberta Napolitano, Chiara Molinari, Martina Valgiusti, Daniele Santini, Francesco Giuseppe Foschi, Giorgio Ercolani, Umberto Vespasiani Gentilucci, Luca Faloppi, Mario Scartozzi, Giovanni Luca Frassineti, Andrea Casadei Gardini

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Sirtuins (SIRT), first described as nicotinamide adenine dinucleotide (NAD+)-dependent type III histone deacetylases, are produced by cells to support in the defense against chronic stress conditions such as metabolic syndromes, neurodegeneration, and cancer. SIRT-3 is one of the most studied members of the mitochondrial sirtuins family. In particular, its involvement in metabolic diseases and its dual role in cancer have been described. In the present review, based on the evidence of SIRT-3 involvement in metabolic dysfunctions, we aimed to provide an insight into the multifaceted role of SIRT-3 in many solid and hematological tumors with a particular focus on hepatocellular carcinoma (HCC). SIRT-3 regulatory effect and involvement in metabolism dysfunctions may have strong implications in HCC development and treatment. Research literature widely reports the relationship between metabolic disorders and HCC development. This evidence suggests a putative bridge role of SIRT-3 between metabolic diseases and HCC. However, further studies are necessary to demonstrate such interconnection.

Original languageEnglish
Pages (from-to)1872-1880
Number of pages9
JournalDigestive Diseases and Sciences
Volume62
Issue number8
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Sirtuins
Hepatocellular Carcinoma
Neoplasms
Metabolic Diseases
Group III Histone Deacetylases
NAD

Keywords

  • Hepatocellular carcinoma
  • Metabolism
  • SIRT-3
  • Tumor suppressor

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma. / De Matteis, Serena; Granato, Anna Maria; Napolitano, Roberta; Molinari, Chiara; Valgiusti, Martina; Santini, Daniele; Foschi, Francesco Giuseppe; Ercolani, Giorgio; Vespasiani Gentilucci, Umberto; Faloppi, Luca; Scartozzi, Mario; Frassineti, Giovanni Luca; Casadei Gardini, Andrea.

In: Digestive Diseases and Sciences, Vol. 62, No. 8, 01.08.2017, p. 1872-1880.

Research output: Contribution to journalReview article

De Matteis, Serena ; Granato, Anna Maria ; Napolitano, Roberta ; Molinari, Chiara ; Valgiusti, Martina ; Santini, Daniele ; Foschi, Francesco Giuseppe ; Ercolani, Giorgio ; Vespasiani Gentilucci, Umberto ; Faloppi, Luca ; Scartozzi, Mario ; Frassineti, Giovanni Luca ; Casadei Gardini, Andrea. / Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma. In: Digestive Diseases and Sciences. 2017 ; Vol. 62, No. 8. pp. 1872-1880.
@article{225677ffa78046ceb9658f4f8f0ab6ee,
title = "Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma",
abstract = "Sirtuins (SIRT), first described as nicotinamide adenine dinucleotide (NAD+)-dependent type III histone deacetylases, are produced by cells to support in the defense against chronic stress conditions such as metabolic syndromes, neurodegeneration, and cancer. SIRT-3 is one of the most studied members of the mitochondrial sirtuins family. In particular, its involvement in metabolic diseases and its dual role in cancer have been described. In the present review, based on the evidence of SIRT-3 involvement in metabolic dysfunctions, we aimed to provide an insight into the multifaceted role of SIRT-3 in many solid and hematological tumors with a particular focus on hepatocellular carcinoma (HCC). SIRT-3 regulatory effect and involvement in metabolism dysfunctions may have strong implications in HCC development and treatment. Research literature widely reports the relationship between metabolic disorders and HCC development. This evidence suggests a putative bridge role of SIRT-3 between metabolic diseases and HCC. However, further studies are necessary to demonstrate such interconnection.",
keywords = "Hepatocellular carcinoma, Metabolism, SIRT-3, Tumor suppressor",
author = "{De Matteis}, Serena and Granato, {Anna Maria} and Roberta Napolitano and Chiara Molinari and Martina Valgiusti and Daniele Santini and Foschi, {Francesco Giuseppe} and Giorgio Ercolani and {Vespasiani Gentilucci}, Umberto and Luca Faloppi and Mario Scartozzi and Frassineti, {Giovanni Luca} and {Casadei Gardini}, Andrea",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s10620-017-4615-x",
language = "English",
volume = "62",
pages = "1872--1880",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma

AU - De Matteis, Serena

AU - Granato, Anna Maria

AU - Napolitano, Roberta

AU - Molinari, Chiara

AU - Valgiusti, Martina

AU - Santini, Daniele

AU - Foschi, Francesco Giuseppe

AU - Ercolani, Giorgio

AU - Vespasiani Gentilucci, Umberto

AU - Faloppi, Luca

AU - Scartozzi, Mario

AU - Frassineti, Giovanni Luca

AU - Casadei Gardini, Andrea

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Sirtuins (SIRT), first described as nicotinamide adenine dinucleotide (NAD+)-dependent type III histone deacetylases, are produced by cells to support in the defense against chronic stress conditions such as metabolic syndromes, neurodegeneration, and cancer. SIRT-3 is one of the most studied members of the mitochondrial sirtuins family. In particular, its involvement in metabolic diseases and its dual role in cancer have been described. In the present review, based on the evidence of SIRT-3 involvement in metabolic dysfunctions, we aimed to provide an insight into the multifaceted role of SIRT-3 in many solid and hematological tumors with a particular focus on hepatocellular carcinoma (HCC). SIRT-3 regulatory effect and involvement in metabolism dysfunctions may have strong implications in HCC development and treatment. Research literature widely reports the relationship between metabolic disorders and HCC development. This evidence suggests a putative bridge role of SIRT-3 between metabolic diseases and HCC. However, further studies are necessary to demonstrate such interconnection.

AB - Sirtuins (SIRT), first described as nicotinamide adenine dinucleotide (NAD+)-dependent type III histone deacetylases, are produced by cells to support in the defense against chronic stress conditions such as metabolic syndromes, neurodegeneration, and cancer. SIRT-3 is one of the most studied members of the mitochondrial sirtuins family. In particular, its involvement in metabolic diseases and its dual role in cancer have been described. In the present review, based on the evidence of SIRT-3 involvement in metabolic dysfunctions, we aimed to provide an insight into the multifaceted role of SIRT-3 in many solid and hematological tumors with a particular focus on hepatocellular carcinoma (HCC). SIRT-3 regulatory effect and involvement in metabolism dysfunctions may have strong implications in HCC development and treatment. Research literature widely reports the relationship between metabolic disorders and HCC development. This evidence suggests a putative bridge role of SIRT-3 between metabolic diseases and HCC. However, further studies are necessary to demonstrate such interconnection.

KW - Hepatocellular carcinoma

KW - Metabolism

KW - SIRT-3

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=85019605997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019605997&partnerID=8YFLogxK

U2 - 10.1007/s10620-017-4615-x

DO - 10.1007/s10620-017-4615-x

M3 - Review article

C2 - 28527050

AN - SCOPUS:85019605997

VL - 62

SP - 1872

EP - 1880

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 8

ER -